Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



GOODMAN COREY S Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 venBio Global Strategic Fund III, L.P. (10% Owner) has filed a Form 4 on Ventyx Biosciences, Inc.
Txns: Granted 13,301 options to buy @ $16.54, valued at $220k
Granted 13,301 options to buy @ $16.54, valued at $220k
05/27/2022 4 venBio Global Strategic Fund III, L.P. (10% Owner) has filed a Form 4 on Elevation Oncology, Inc.
Txns: Sold 702,737 shares @ $4.1236, valued at $2.9M
05/17/2022 4 venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns: Sold 35,850 shares @ $10.4453, valued at $374.5k
Sold 95,800 shares @ $10.4499, valued at $1M
05/12/2022 4 venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns: Sold 18,676 shares @ $10.3807, valued at $193.9k
Sold 17,700 shares @ $10.3752, valued at $183.6k
Sold 124,525 shares @ $10.394, valued at $1.3M
05/09/2022 4 venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns: Sold 20,743 shares @ $10.37, valued at $215.1k
Sold 48,334 shares @ $10.3702, valued at $501.2k
Sold 17,600 shares @ $10.374, valued at $182.6k
05/04/2022 4 venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns: Sold 153,700 shares @ $10.3837, valued at $1.6M
Sold 79,475 shares @ $10.3735, valued at $824.4k
Sold 37,500 shares @ $10.3713, valued at $388.9k
04/29/2022 4 venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns: Sold 47,396 shares @ $10.3802, valued at $492k
Sold 73,400 shares @ $10.3806, valued at $761.9k
Sold 69,230 shares @ $10.3808, valued at $718.7k
04/26/2022 4 venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns: Sold 37,430 shares @ $10.3883, valued at $388.8k
Sold 27,668 shares @ $10.3876, valued at $287.4k
Sold 64,683 shares @ $10.3823, valued at $671.6k
04/21/2022 4 venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns: Sold 399,923 shares @ $10.4151, valued at $4.2M
Sold 85,611 shares @ $10.3887, valued at $889.4k
Sold 62,200 shares @ $10.3837, valued at $645.9k
10/26/2021 4 venBio Global Strategic Fund, L.P. (10% Owner) has filed a Form 4 on Metacrine, Inc.
Txns: Sold 75,035 shares @ $1.6383, valued at $122.9k
Sold 540,667 shares @ $1.4907, valued at $806k
10/25/2021 4 venBio Global Strategic Fund III, L.P. (10% Owner) has filed a Form 4 on Ventyx Biosciences, Inc.
Txns: Converted 3,684,769 shares @ $0
Bought 312,500 shares @ $16, valued at $5M
Converted 3,289,742 preferred shares @ $0
Converted 395,027 preferred shares @ $0
07/01/2021 4 venBio Global Strategic Fund III, L.P. (10% Owner) has filed a Form 4 on Elevation Oncology, Inc.
Txns: Converted 1,983,167 shares @ $0
Bought 625,000 shares @ $16, valued at $10M
Converted 8,380,034 preferred shares @ $0
06/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/29/2021 4 venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on IMPEL NEUROPHARMA INC
Txns: Converted 2,309,791 shares @ $0
Bought 450,000 shares @ $15, valued at $6.8M
Converted 5,876,034 options to buy @ $0
Converted 8,201,930 options to buy @ $0
Converted 8,845,942 options to buy @ $0
Converted 13,233,885 options to buy @ $0
Converted convertible notes @ $0
04/26/2021 4 venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on IMPEL NEUROPHARMA INC
Txns: Acquired convertible notes @ $0
09/22/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/12/2020 4 venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns: Converted 3,473,374 shares @ $0
Bought 200,000 shares @ $15, valued at $3M
Converted 12,500,000 preferred shares @ $0
Converted 8,753,350 preferred shares @ $0
Converted 3,644,624 preferred shares @ $0
07/21/2020 4 GOODMAN COREY S (10% Owner) has filed a Form 4 on ALX ONCOLOGY HOLDINGS INC
Txns: Converted 3,100,020 shares @ $0
Bought 850,000 shares @ $19, valued at $16.2M
Converted 3,941,949 shares @ $0
Converted 93,969 shares @ $0
Converted 52,647 shares @ $0
Converted 3,100,020 options to buy @ $0
Converted 2,398,588 options to buy @ $0
Converted 490,411 options to buy @ $0
Converted 1,052,950 options to buy @ $0
Converted 78,175 options to buy @ $0
Converted 15,794 options to buy @ $0
07/17/2020 4 GOODMAN COREY S (10% Owner) has filed a Form 4 on ALX ONCOLOGY HOLDINGS INC
Txns: Granted 24,009 options to buy @ $19, valued at $456.2k
07/06/2020 4 venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 108,064 shares @ $34.4519, valued at $3.7M
Sold 3,800 shares @ $33.633, valued at $127.8k
Sold 4,603 shares @ $33.8304, valued at $155.7k
03/06/2020 4 venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 35,650 shares @ $23.8083, valued at $848.8k
Sold 8,500 shares @ $23.5307, valued at $200k
Sold 1,800 shares @ $23.7949, valued at $42.8k
03/03/2020 4 venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 5,100 shares @ $21.3044, valued at $108.7k
Sold 10,297 shares @ $23.061, valued at $237.5k
Sold 6,401 shares @ $22.9962, valued at $147.2k
02/27/2020 4 venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 1,600 shares @ $23.6725, valued at $37.9k
Sold 2,523 shares @ $22.4397, valued at $56.6k
Sold 1,781 shares @ $22.54, valued at $40.1k
02/12/2020 4 venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 7,836 shares @ $27.0761, valued at $212.2k
Sold 2,184 shares @ $27.0458, valued at $59.1k
Sold 6 shares @ $27.14, valued at $162.8
02/10/2020 4 venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 6,102 shares @ $27.0329, valued at $165k
02/06/2020 4 venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 53,731 shares @ $25.6496, valued at $1.4M
Sold 28,608 shares @ $25.9909, valued at $743.5k
01/14/2020 4 venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 494,000 shares @ $20.23, valued at $10M
01/10/2020 4 venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 15,677 shares @ $19.8606, valued at $311.4k
01/08/2020 4 venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 42,221 shares @ $19.6438, valued at $829.4k
Sold 31,000 shares @ $20.1661, valued at $625.1k
01/06/2020 4 venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 23,000 shares @ $19.9351, valued at $458.5k
Sold 12,498 shares @ $19.3002, valued at $241.2k
01/03/2020 4 venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 14,324 shares @ $23.9639, valued at $343.3k
06/25/2019 4 venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Bought 250,000 shares @ $16, valued at $4M
Converted 3,469,759 shares @ $0
Converted 235,099 shares @ $0
Converted 10,666,667 preferred shares @ $0
Converted 722,737 preferred shares @ $0
04/01/2019 4 venBio Global Strategic Fund, L.P. (10% Owner) has filed a Form 4 on PRECISION BIOSCIENCES INC
Txns: Bought 50,000 shares @ $16, valued at $800k
Converted 3,747,623 shares @ $0
Converted 467,518 shares @ $0
Converted 8,000,000 preferred shares @ $0
Converted 998,004 preferred shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy